Search

everythinglearnresearchcommunity

for

Search:↓

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

A new ARID1B gene variation causes Coffin-Siris syndrome 1 and early high myopia in a Chinese family.

Generic drug inserts in Saudi Arabia often have inaccurate information, needing better regulation and quality control.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Isoalantolactone promotes hair growth by activating specific cell pathways.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Mutations in certain receptors can cause diseases and offer new treatment options.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Oral Apremilast effectively treats alopecia areata in most patients.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Most adverse reactions to the treatment were mild, with nausea being the most common.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The AUTS2 gene is linked to neurological disorders and may affect human brain development and cognition.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

ASA and CM may protect the brain and work better together.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.